Gentler resuscitation may protect fragile lungs in tiniest babies

NCT ID NCT01223274

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests whether using continuous positive airway pressure (CPAP) or positive end-expiratory pressure (PEEP) during resuscitation helps extremely low birth weight infants (born before 28 weeks) breathe better and avoid lung damage. Half of the babies receive standard care with 100% oxygen alone, while the other half get oxygen plus CPAP or PEEP through a facemask. The goal is to see if this gentler approach is feasible and reduces the need for breathing tubes and long-term ventilation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CPAP/PEEP (continuous positive airway pressure/positive end-expiratory pressure) via Neopuff device
What this could lead to
If this approach works, it could lead to better breathing support for the tiniest newborns, potentially reducing lung injury and the need for long-term ventilation.
What could go wrong
This is an early pilot study with only 104 infants, so results may not be conclusive. The intervention may not improve outcomes and could carry risks like lung overinflation or air leaks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Case Western Reserve University, Rainbow Babies and Children's Hospital

    Cleveland, Ohio, 44106, United States

  • Cincinnati Children's Medical Center

    Cincinnati, Ohio, 45267, United States

  • RTI International

    Durham, North Carolina, 27705, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35233, United States

  • University of California at San Diego

    San Diego, California, 92103-8774, United States

  • University of Miami

    Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.